A team led by U-M researchers discovered that a noninvasive imaging biomarker can identify small airway damage in COPD patients.

A new tool that takes into account personalized risks and benefits, and allows for a range of patient preferences, will help clinicians decide whom to screen for lung cancer.

While gut bacteria have been credited with boosting the body’s immune system, bacteria in the lungs may play a more direct role in protecting their own backyard.

Successfully tested in mice, targeted drug and gene therapies might one day benefit patients with a deadly lung disease, new U-M research finds.

Halting the voyage of gut bacteria to the brain could help prevent harmful brain inflammation after a sepsis infection, a new study shows.

Biomedical engineering is bringing gas chromatography technology bedside, potentially making detection of certain conditions dramatically easier.